We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Clinical Trials Transformation Initiative: Methodology supporting the mission.
- Authors
Corneli, Amy; Hallinan, Zachary; Hamre, Gerrit; Perry, Brian; Goldsack, Jennifer C.; Calvert, Sara B.; Forrest, Annemarie
- Abstract
The mission of the Clinical Trials Transformation Initiative, a public–private partnership co-founded by the U.S. Food and Drug Administration and Duke University, is to develop and drive adoption of practices that will increase the quality and efficiency of clinical trials. The Clinical Trials Transformation Initiative works collaboratively with key stakeholders, implements “fit-for-purpose” evidence-gathering projects, and develops actionable recommendations and tools to address the challenges faced by the clinical trials enterprise. In pursuit of its mission, The Clinical Trials Transformation Initiative follows an innovative and collaborative, five-step methodology: (1) state the problem and identify impediments to research, (2) gather evidence to identify gaps and barriers, (3) explore results by analyzing and interpreting findings, (4) finalize solutions by developing recommendations and tools, and (5) drive adoption through disseminating and implementing recommendations and tools. This article describes each step of the Clinical Trials Transformation Initiative's methodology, with a specific focus on describing the evidence-gathering activities.
- Subjects
UNITED States; CLINICAL trials; HEALTH services accessibility; INTERPROFESSIONAL relations; QUALITY assurance; STATISTICS; DATA analysis; ORGANIZATIONAL goals; SOCIETIES
- Publication
Clinical Trials, 2018, Vol 15, p13
- ISSN
1740-7745
- Publication type
Article
- DOI
10.1177/1740774518755054